GB0515430D0 - Preparation of cabergoline - Google Patents

Preparation of cabergoline

Info

Publication number: GB0515430D0
Authority: GB; United Kingdom
Prior art keywords: cabergoline; preparation
Prior art date: 2005-07-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0515430.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Resolution Chemicals Ltd

Original Assignee

Resolution Chemicals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-27

Filing date

2005-07-27

Publication date

2005-08-31

2005-07-27 Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd

2005-07-27 Priority to GBGB0515430.7A priority Critical patent/GB0515430D0/en

2005-08-31 Publication of GB0515430D0 publication Critical patent/GB0515430D0/en

2005-11-07 Priority to US11/268,118 priority patent/US7339060B2/en

2006-03-23 Priority to EP06726488A priority patent/EP1861398A2/en

2006-03-23 Priority to CA002602898A priority patent/CA2602898A1/en

2006-03-23 Priority to EP09170766A priority patent/EP2135869A1/en

2006-03-23 Priority to AU2006226135A priority patent/AU2006226135A1/en

2006-03-23 Priority to PCT/GB2006/001068 priority patent/WO2006100492A2/en

2006-03-23 Priority to JP2008502478A priority patent/JP2008534484A/en

2006-03-23 Priority to BRPI0609425-2A priority patent/BRPI0609425A2/en

2006-03-23 Priority to NZ561073A priority patent/NZ561073A/en

2006-07-27 Priority to AU2006273831A priority patent/AU2006273831A1/en

2006-07-27 Priority to JP2008523446A priority patent/JP2009502895A/en

2006-07-27 Priority to CA002616738A priority patent/CA2616738A1/en

2006-07-27 Priority to PCT/GB2006/002784 priority patent/WO2007012846A1/en

2006-07-27 Priority to ZA200801151A priority patent/ZA200801151B/en

2006-07-27 Priority to CNA200680027137XA priority patent/CN101228159A/en

2006-07-27 Priority to EP06765107A priority patent/EP1912984A1/en

2007-08-30 Priority to IL185600A priority patent/IL185600A0/en

2007-09-18 Priority to NO20074758A priority patent/NO20074758L/en

2008-01-06 Priority to IL188598A priority patent/IL188598A0/en

2008-01-24 Priority to NO20080461A priority patent/NO20080461L/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0515430.7A 2005-03-23 2005-07-27 Preparation of cabergoline Ceased GB0515430D0 (en)

Priority Applications (21)

Application Number	Priority Date	Filing Date	Title
GBGB0515430.7A GB0515430D0 (en)	2005-07-27	2005-07-27	Preparation of cabergoline
US11/268,118 US7339060B2 (en)	2005-03-23	2005-11-07	Preparation of cabergoline
EP06726488A EP1861398A2 (en)	2005-03-23	2006-03-23	Preparation of cabergoline
CA002602898A CA2602898A1 (en)	2005-03-23	2006-03-23	Preparation of cabergoline
EP09170766A EP2135869A1 (en)	2005-03-23	2006-03-23	Preparation of a crystalline form of cabergoline
AU2006226135A AU2006226135A1 (en)	2005-03-23	2006-03-23	Preparation of cabergoline
PCT/GB2006/001068 WO2006100492A2 (en)	2005-03-23	2006-03-23	Preparation of cabergoline
JP2008502478A JP2008534484A (en)	2005-03-23	2006-03-23	Production of cabergoline
BRPI0609425-2A BRPI0609425A2 (en)	2005-03-23	2006-03-23	cabergoline preparation
NZ561073A NZ561073A (en)	2005-03-23	2006-03-23	Preparation of cabergoline polymorph
EP06765107A EP1912984A1 (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline form i
AU2006273831A AU2006273831A1 (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline Form I
JP2008523446A JP2009502895A (en)	2005-07-27	2006-07-27	Preparation of cabergoline solvates and cabergoline form I
CA002616738A CA2616738A1 (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline form i
PCT/GB2006/002784 WO2007012846A1 (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline form i
ZA200801151A ZA200801151B (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline Form 1
CNA200680027137XA CN101228159A (en)	2005-07-27	2006-07-27	Solvate of cabergoline and preparations of cabergoline form i
IL185600A IL185600A0 (en)	2005-03-23	2007-08-30	A method for preparing cabergoline
NO20074758A NO20074758L (en)	2005-03-23	2007-09-18	Manufacture of cabergoline
IL188598A IL188598A0 (en)	2005-07-27	2008-01-06	A solvate of cabergoline and methods of preparing cabergoline form 1 utilizing the same
NO20080461A NO20080461L (en)	2005-07-27	2008-01-24	Solvent of cabergoline and preparations of cobergoline form I

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0515430.7A GB0515430D0 (en)	2005-07-27	2005-07-27	Preparation of cabergoline

Publications (1)

Publication Number	Publication Date
GB0515430D0 true GB0515430D0 (en)	2005-08-31

Family

ID=34976701

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0515430.7A Ceased GB0515430D0 (en)	2005-03-23	2005-07-27	Preparation of cabergoline

Country Status (10)

Country	Link
EP (1)	EP1912984A1 (en)
JP (1)	JP2009502895A (en)
CN (1)	CN101228159A (en)
AU (1)	AU2006273831A1 (en)
CA (1)	CA2616738A1 (en)
GB (1)	GB0515430D0 (en)
IL (1)	IL188598A0 (en)
NO (1)	NO20080461L (en)
WO (1)	WO2007012846A1 (en)
ZA (1)	ZA200801151B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1925616A1 (en) *	2006-10-26	2008-05-28	LEK Pharmaceuticals D.D.	Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
CN104147041B (en) *	2014-08-17	2017-02-22	山西振东安特生物制药有限公司	Dispersion preparation containing colloidal bismuth pectin and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0007308D0 (en) *	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Process for preparing crystalline form \| of cabergoline
CN1642953A (en) *	2002-03-15	2005-07-20	法玛西雅公司	Process for preparing crystalline form I of cabergoline
BR0308304A (en) *	2002-03-15	2004-12-28	Pharmacia Corp	Process for preparing crystalline cabergoline form I
CA2525104A1 (en) *	2003-05-08	2004-11-25	Ivax Pharmaceuticals S.R.O.	Polymorphs of cabergoline

2005
- 2005-07-27 GB GBGB0515430.7A patent/GB0515430D0/en not_active Ceased
2006
- 2006-07-27 AU AU2006273831A patent/AU2006273831A1/en not_active Abandoned
- 2006-07-27 ZA ZA200801151A patent/ZA200801151B/en unknown
- 2006-07-27 JP JP2008523446A patent/JP2009502895A/en not_active Withdrawn
- 2006-07-27 CN CNA200680027137XA patent/CN101228159A/en active Pending
- 2006-07-27 EP EP06765107A patent/EP1912984A1/en not_active Withdrawn
- 2006-07-27 CA CA002616738A patent/CA2616738A1/en not_active Abandoned
- 2006-07-27 WO PCT/GB2006/002784 patent/WO2007012846A1/en active Application Filing
2008
- 2008-01-06 IL IL188598A patent/IL188598A0/en unknown
- 2008-01-24 NO NO20080461A patent/NO20080461L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20080461L (en)	2008-04-18
ZA200801151B (en)	2009-04-29
EP1912984A1 (en)	2008-04-23
CN101228159A (en)	2008-07-23
JP2009502895A (en)	2009-01-29
WO2007012846A1 (en)	2007-02-01
IL188598A0 (en)	2008-04-13
AU2006273831A1 (en)	2007-02-01
CA2616738A1 (en)	2007-02-01

Publication	Publication Date	Title
PT1802579E (en)	2014-02-17	Derivatives of 3-arylaminopyridine
HRP20150012T1 (en)	2015-03-27	39-desmethoxy derivatives of rapamycin
ZA200710877B (en)	2008-12-31	Preparation of syngas
IL184036A0 (en)	2007-10-31	Preparation of rosuvastatin
ZA200805147B (en)	2010-05-26	Solid preparation
IL185757A0 (en)	2008-01-06	Methods of decreasing calcifcation
EP1942734A4 (en)	2010-04-07	Preparation of aprepitant
GB0421149D0 (en)	2004-10-27	Preparation of oxycodone
EP1893625A4 (en)	2012-12-26	Methods for the preparation of 9-deazapurine derivatives
EP1912499A4 (en)	2010-03-31	Preparation of montelukast
HK1122797A1 (en)	2009-05-29	Derivatives of pyrido
HK1161122A1 (en)	2012-08-24	Use of 24-norudca 24-norudca
IL187407A0 (en)	2008-02-09	Sugar-coated preparation
EP1938808A4 (en)	2009-01-14	Preparation for external use
EP1964538A4 (en)	2013-04-10	Preparation method of pharmaceutials
GB0910201D0 (en)	2009-07-29	The preparation method of 2-deoxy-l-ribose
HK1119676A1 (en)	2009-03-13	Processes for the preparation of cyclopropyl-amide derivatives
IL189297A0 (en)	2008-06-05	Preparation of thioalkylamines with high yields
IL187948A0 (en)	2008-03-20	Preparation of rosuvastatin
GB0515430D0 (en)	2005-08-31	Preparation of cabergoline
GB0505965D0 (en)	2005-04-27	Preparation of cabergoline
GB0409250D0 (en)	2004-05-26	Preparation of cabergoline
GB0508439D0 (en)	2005-06-01	Design of structural elements
HUP0500461A3 (en)	2009-04-28	Pyperazine derivatives of alkyl-oxindoles
PL381715A1 (en)	2007-06-25	New piperazinic derivatives of dialkyloxindole

Legal Events

Date	Code	Title	Description
2008-02-20	AT	Applications terminated before publication under section 16(1)